Assistant Controller, Valo Health
$144-170k
+ Annual incentive program
More information about location
3+ days a week in office (Lexington, MA)
Platform for drug development and discovery
Open for applications
Platform for drug development and discovery
101-200 employees
Open for applications
$144-170k
+ Annual incentive program
More information about location
3+ days a week in office (Lexington, MA)
101-200 employees
Company mission
To make the drug discovery and development process faster, less expensive, and with a higher probability of success.
Role
Who you are
- The candidate will have a strong technical knowledge of U.S. GAAP and demonstrated success scaling accounting operations and improving processes within a fast-paced, evolving organization
- Bachelor’s degree in accounting or related field; CPA required
- Minimum of 7+ years of progressive accounting experience, with 3+ years of Big Four public accounting
- Life sciences or biotech industry experience strongly preferred
- Experience with Valo’s finance systems a plus, including NetSuite, FloQast, Prendio, and Adaptive Insights
- Strong technical knowledge of U.S. GAAP and comfort applying it within a fast-paced, evolving organization
- Demonstrated ability to scale accounting operations, improve processes, and take on expanded responsibilities as the company grows in size and complexity
- Proven leadership capabilities, including the ability to mentor and develop staff as the finance function evolves
- A continuous improvement mindset with a passion for building scalable, high-performing finance processes
- Excellent communication, collaboration, and interpersonal skills, with the ability to work effectively across departments
- High level of integrity, sound judgment, and strong commitment to ethical behavior and compliance with all policies and regulations
- Strong analytical, planning, and problem-solving skills, with the ability to resolve issues proactively
- Exceptional attention to detail and commitment to maintaining high-quality, accurate financial data
- Team-oriented and adaptable, able to thrive in a dynamic biotech environment with evolving priorities and timelines
- Advanced Excel proficiency required
What the job involves
- Reporting to the Controller, the Assistant Controller will lead monthly, quarterly and annual close processes and ensure the accuracy, timeliness, and integrity of financial data
- The candidate will join a Finance team that values integrity, inclusiveness, executing for results, success as a team, and strong customer service
- Lead monthly, quarterly, and annual close activities, ensuring timely, accurate, and complete financial records and reporting in accordance with US GAAP, legal requirements, and Company policies
- Prepare and review monthly journal entries, account analyses, balance sheet reconciliations, financial statements, and supporting reports with a focus on precision and data integrity
- Demonstrated ability to manage revenue recognition for collaboration and milestone arrangements in accordance with U.S GAAP
- Collaborate with Finance team members to prepare internal management reporting packages and various ad-hoc analyses that support strategic decision-making
- Analyze and provide commentary on balance sheet and income statement variances, highlighting key drivers and trends
- Manage corporate consolidations, including oversight of subsidiary reporting requirements and elimination entries
- Oversee fixed asset accounting, including maintenance of the fixed asset subledger, application of capitalization policies, calculation of monthly depreciation, and preparation of related close schedules
- Ensure proper documentation and control over accounting records, maintaining support required for legal, regulatory, and audit compliance
- Support quarterly reviews and annual financial statement audits and assist with other ad hoc projects as directed by the Controller
- Prepare annual regulatory reports and filings, such as property tax and other required submissions
- Identify emerging business, operational, or technical risks and incorporate relevant updates into SOX compliance program documentation in a timely manner
- Lead the preparation of the annual SOX risk assessment, including determining materiality thresholds, identifying in-scope processes, and mapping significant accounts to key assertions and controls
- Interface with external auditors for annual audits, quarterly reviews, and internal control testing, ensuring timely delivery of required schedules and documentation
- Participate in special projects and ad-hoc financial analyses in support of finance department priorities and broader company initiatives
Our take
Drug development is a critical component of health care. Reducing costs, improving discovery processes, and accelerating drug development are all critical to success in the drug pipeline. Using human-centric data and ML-anchored computation, Valo Health’s integrated drug development platform, known as Opal, improves outcomes in drug development, by leveraging advanced data analysis.
Drug development entails a variety of steps including molecule discovery, clinical development, and target discovery. With the vast amount of data that is generated, a system like Opal incentivizes investment in outcomes that are more likely to correspond with effective treatments. This reduces the number and expense of clinical trials needed to demonstrate drug effectiveness.
There are a variety of competitors in the data-driven drug discovery field, including insitro, Atomwise, and Exscietia, but this vast market should still offer enough space for Valo Health to grow. In 2021, the company experienced a set-back in the surprise calling off of a merger that would have seen it go public, but despite this has continued to operate well and advance towards its goal of transforming the drug development process.
Freddie
Company Specialist at Welcome to the Jungle
Insights
-23% employee growth in 12 months
Company
Funding (last 2 of 7 rounds)
Nov 2021
$1m
LATE VC
Jul 2021
$33.5m
LATE VC
Total funding: $487.5m
Company benefits
- Medical, Dental, and Vision Insurance
- Flexible Time-off
- 401K
- Corporate Engagement Opportunities with Local Non-Profit Organizations
- Commuter Reimbursement
- Fitness Reimbursement
- Pet Insurance
Company HQ
Back Bay East, Boston, MA
Leadership
Brian Alexander
(CEO)Also a Partner at Flagship Pioneering. Previously SVP of Genentech, CEO of Foundation Medicine and was a n Associate Professor at Harvard Medical School.
Brett Blackman
(COO)Member of the Board of Directors at Stanley Manne Children's Research Institute. Previously Interim Chief Scientific Officer at Omega Therapeutics and was a Strategic R&D Advisor at Ohana Biosciences, Inc.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job